JP2007537169A5 - - Google Patents

Download PDF

Info

Publication number
JP2007537169A5
JP2007537169A5 JP2007511867A JP2007511867A JP2007537169A5 JP 2007537169 A5 JP2007537169 A5 JP 2007537169A5 JP 2007511867 A JP2007511867 A JP 2007511867A JP 2007511867 A JP2007511867 A JP 2007511867A JP 2007537169 A5 JP2007537169 A5 JP 2007537169A5
Authority
JP
Japan
Prior art keywords
sodium
medium
agent
acid
medium according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007511867A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007537169A (ja
JP5154924B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2005/000317 external-priority patent/WO2005107713A2/en
Publication of JP2007537169A publication Critical patent/JP2007537169A/ja
Publication of JP2007537169A5 publication Critical patent/JP2007537169A5/ja
Application granted granted Critical
Publication of JP5154924B2 publication Critical patent/JP5154924B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007511867A 2004-05-11 2005-05-11 ジェランガムを含む膨張可能な投与形態 Expired - Fee Related JP5154924B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400755 2004-05-11
DKPA200400755 2004-05-11
PCT/DK2005/000317 WO2005107713A2 (en) 2004-05-11 2005-05-11 Swellable dosage form comprising gellan gum

Publications (3)

Publication Number Publication Date
JP2007537169A JP2007537169A (ja) 2007-12-20
JP2007537169A5 true JP2007537169A5 (https=) 2008-06-26
JP5154924B2 JP5154924B2 (ja) 2013-02-27

Family

ID=34967246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007511867A Expired - Fee Related JP5154924B2 (ja) 2004-05-11 2005-05-11 ジェランガムを含む膨張可能な投与形態

Country Status (8)

Country Link
US (2) US8383154B2 (https=)
EP (2) EP1758557B1 (https=)
JP (1) JP5154924B2 (https=)
AT (1) ATE516019T1 (https=)
CA (1) CA2566793C (https=)
DK (2) DK1758557T3 (https=)
ES (2) ES2517244T3 (https=)
WO (1) WO2005107713A2 (https=)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
WO2004084868A1 (en) 2003-03-26 2004-10-07 Egalet A/S Morphine controlled release system
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060275366A1 (en) * 2005-06-02 2006-12-07 Schering Corporation Controlled-release formulation
EP3000460A1 (en) * 2005-09-15 2016-03-30 Genzyme Corporation Sachet formulation for amine polymers
WO2007034287A2 (en) * 2005-09-19 2007-03-29 University Of The Witwatersrand, Johannesburg Oramucosal pharmaceutical dosage form
EP2104493A2 (en) * 2007-01-16 2009-09-30 Egalet A/S Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
US8563066B2 (en) * 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
US9237972B2 (en) * 2008-12-16 2016-01-19 Kimberly-Clark Worldwide, Inc. Liquid surfactant compositions that adhere to surfaces and solidify and swell in the presence of water and articles using the same
EP2208493A1 (en) * 2009-01-15 2010-07-21 Sandoz AG Method and device for oral application of a composition
EP2389169A1 (en) * 2009-01-26 2011-11-30 Egalet A/S Controlled release formulations with continuous efficacy
CA2751667C (en) 2009-02-06 2016-12-13 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
CA2751627A1 (en) 2009-02-06 2010-08-12 Egalet Ltd. Pharmaceutical compositions resistant to abuse
CN102348457A (zh) 2009-03-11 2012-02-08 奥默罗斯公司 预防和治疗成瘾的组合物和方法
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
FR2955252B1 (fr) * 2010-01-21 2012-03-23 Patrick Lesage Materiau d'insertion destine a elargir le sillon gingival
JP2013522246A (ja) 2010-03-15 2013-06-13 フェロサン メディカル デバイシーズ エイ/エス 止血および/または創傷治癒を促進するための方法
WO2012037117A1 (en) 2010-09-13 2012-03-22 Bev-Rx, Inc. Aqueous drug delivery system comprising off - flavor masking agent
US9132291B2 (en) 2010-10-05 2015-09-15 Dfb Technology, Ltd. Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
US8691275B2 (en) * 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
AU2012214553B2 (en) 2011-02-11 2015-07-09 Sociétés des Produits Nestlé S.A. Multiparticulate L-menthol formulations and related methods
JP5226097B2 (ja) * 2011-03-30 2013-07-03 株式会社ファンケル サプリメントを内包する蓋体とサプリメント分散媒を充填したボトルからなるボトル入り飲料
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
US8898912B2 (en) * 2011-08-29 2014-12-02 Adam Leffler Spoon delivery device
CA2852447A1 (en) * 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
WO2013095215A1 (en) * 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
US9452135B2 (en) 2012-03-20 2016-09-27 Particle Dynamics International, Llc Gelling agent-based dosage form
WO2013169925A1 (en) * 2012-05-08 2013-11-14 Metronomx Novel formulations of nitrofurans including nifurtimox with enhanced activity with lower toxicity
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
AU2013285988A1 (en) 2012-07-06 2015-02-12 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
EP2934422A4 (en) * 2012-12-23 2016-07-20 Vadim Zelikman RUBBER SUPPORT FOR A MEDICAMENT, MEDIUM AND METHOD
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
ES2706152T3 (es) 2013-04-23 2019-03-27 Zx Pharma Llc Composición entérica de múltiples partículas revestida con subrevestimiento proteico
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
CN105451723A (zh) * 2013-06-26 2016-03-30 爱荷华大学研究基金会 经口药物递送装置和其使用方法
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ/エス 押し出し増強因子を含んでいる乾燥組成物
SI3105218T1 (sl) 2014-02-13 2019-11-29 Incyte Corp Ciklopropilamini kot inhibitorji LSD1
MX373103B (es) 2014-02-13 2020-04-17 Incyte Holdings Corp Ciclopropilaminas como inhibidores de desmetilasa específica de lisina 1 (lsd1).
CA2943422C (en) * 2014-04-29 2020-03-10 The Procter & Gamble Company Bismuth-containing liquid pharmaceutical suspensions
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
CN105560281A (zh) * 2014-10-08 2016-05-11 华仁药业股份有限公司 一种混合糖电解质注射液及其制备方法
AU2015333206B2 (en) 2014-10-13 2019-07-11 Ferrosan Medical Devices A/S. Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
US10792301B2 (en) * 2015-02-13 2020-10-06 The University Of Toledo Therapeutic polysaccharide midi-GAGR and related materials and methods
EP3277689B1 (en) 2015-04-03 2019-09-04 Incyte Corporation Heterocyclic compounds as lsd1 inhibitors
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
GR1008819B (el) 2015-05-22 2016-08-01 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο σκευασμα που περιλαμβανει ατομοξετινη και μεθοδος παρασκευης αυτου
CN107771093B (zh) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 用于混合两种组分和用于在存储条件下保持真空的注射器
LT3334709T (lt) 2015-08-12 2025-03-10 Incyte Holdings Corporation Lsd1 inhibitoriaus druskos
KR20190008265A (ko) 2016-05-06 2019-01-23 피지션즈 씰, 엘엘씨 발레리안 조성물 및 관련 방법
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US10806789B2 (en) 2017-05-12 2020-10-20 The LIV Group Inc. Composition for enhanced absorption of supplements
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
EP3699223A1 (de) * 2019-02-19 2020-08-26 LANXESS Deutschland GmbH Inline ultraschallkontrolle zur detektion des anvernetzens einer kautschukmischung bei der in situ silanisierung von hellen füllstoffen
MX2022005050A (es) * 2019-10-28 2022-07-04 Scherer Technologies Llc R P Cápsulas de gelatina blanda de liberación retardada en entorno de ph más alto.
JP7792917B2 (ja) * 2020-07-10 2025-12-26 アデア ファーマシューティカルズ,インコーポレイテッド 膨潤性経口医薬組成物
FR3119315B1 (fr) * 2021-02-02 2022-12-30 Virbac « gel diffuseur de pheromones »
US20240197635A1 (en) * 2021-03-03 2024-06-20 Veramorph Llc Dissociating polymer matrix compositions of fulvestrant and methods of their making and use
EP4392044A4 (en) * 2021-09-09 2025-01-22 Junion Labs Pte. Ltd. SUPERABSORBENT HYDROGELS WITH LIPASE INHIBITOR
US20260092128A1 (en) * 2022-09-25 2026-04-02 Albert Ludwigs University Of Freiburg Marine polysaccharide networks
AU2023366929A1 (en) 2022-10-25 2025-05-08 Veradermics, Incorporated Compositions and methods of use for modified release minoxidil
CN115566270B (zh) * 2022-11-02 2026-03-27 鹰潭耀宁新能源科技有限公司 一种锂离子电池用电解质及其制备方法
CN116449023B (zh) * 2023-04-10 2024-07-12 浙江伊利康生物技术有限公司 一种血清淀粉样蛋白a检测试剂盒及其制备方法
GB2630304A (en) * 2023-05-22 2024-11-27 Gelteq Ltd Pharmaceutical formulations
CN121793948A (zh) 2023-09-01 2026-04-03 豪夫迈·罗氏有限公司 用于制备半固体组合物的新颖方法及其用途
WO2025191578A1 (en) * 2024-03-14 2025-09-18 Softgel Healthcare Private Limited Gummesule dosage form for the improvement of bioavailability and enhanced patient compliance
DE102024111019A1 (de) 2024-04-19 2025-10-23 Gelita Ag Gelmasse zur Herstellung von Weichkapseln oder Filmen, deren Verwendung und Herstellungsverfahren
CN119756467B (zh) * 2024-12-17 2025-10-03 重庆理工大学 一种温湿度原位检测传感器、湿度传感器制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994260A (en) 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
US4590075A (en) 1984-08-27 1986-05-20 Warner-Lambert Company Elastomer encapsulation of flavors and sweeteners, long lasting flavored chewing gum compositions based thereon and process of preparation
US4824681A (en) 1986-12-19 1989-04-25 Warner-Lambert Company Encapsulated sweetener composition for use with chewing gum and edible products
GB8702411D0 (en) 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
MX9102619A (es) 1990-12-17 1992-06-01 Redding Bruce K Metodo y aparato para revestir materiales.
US5126151A (en) 1991-01-24 1992-06-30 Warner-Lambert Company Encapsulation matrix
US5881926A (en) 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
ATE260646T1 (de) * 1996-04-16 2004-03-15 Novartis Consumer Health Sa Schnell zerfallende orale dosierungsform
CA2262595C (en) * 1996-08-15 2005-10-18 Losan Pharma Gmbh Easy to swallow oral medicament composition
AU5453198A (en) * 1996-11-29 1998-06-22 Monsanto Company Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
US6326028B1 (en) * 1997-10-31 2001-12-04 Monsanto Company Alginate and gellan gum as tablet coating
JP3524359B2 (ja) 1997-12-26 2004-05-10 伊那食品工業株式会社 咀嚼・嚥下困難者用の摂食補助用糊料
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
SK284948B6 (sk) 2000-04-06 2006-03-02 Zentiva, A. S. Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
US6474418B2 (en) 2000-12-07 2002-11-05 Frank's International, Inc. Wellbore fluid recovery system and method
CA2366327A1 (en) 2000-12-21 2002-06-21 Oscar M. Bassinson Personal medication dispensing card
US6589955B2 (en) 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
CA2461616A1 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
CZ12993U1 (cs) 2001-11-23 2003-02-10 Glaxo Group Limited Farmaceutický prostředek
JP3835544B2 (ja) * 2002-09-10 2006-10-18 明治乳業株式会社 ゼリー乾燥物
CN1780880B (zh) 2003-04-25 2010-04-28 雷克特本克斯尔保健(英国)有限公司 可增稠的组合物
WO2005007074A2 (en) * 2003-07-21 2005-01-27 Bio-Dar Ltd. Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention
US9109434B2 (en) 2013-06-09 2015-08-18 Schlumberger Technology Corporation System and method for estimating oil formation volume factor downhole

Similar Documents

Publication Publication Date Title
JP2007537169A5 (https=)
CA2566793A1 (en) A novel dosage form
US12605333B2 (en) Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
US20220241190A1 (en) Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
JPS646172B2 (https=)
JPH08511807A (ja) メトプロロールの24時間放出用の徐放性調剤
JP2018021007A5 (https=)
RU2007111713A (ru) Фармацевтическая композиция для перорального введения в форме частиц с рассчитанным временем высвобождения и быстро распадающиеся таблетки, содержащие указанную композицию
JPH10511407A (ja) 高用量難溶性薬物用持続放出マトリックス
JP6488003B2 (ja) 安定なモンテルカスト溶液
IL292583B1 (en) Delayed release softgel capsules in higher ph environment
AU2014227598B2 (en) Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
JP4472699B2 (ja) 粘度発現性を改良した増粘用組成物
JP5416716B2 (ja) グリコーゲンおよびアルギン酸塩の会合体に基づく徐放性製剤
RU2008136767A (ru) Фармацевтическая композиция флувастатина натрия
JP2015533174A (ja) ピロカルピンの医薬製剤
CN107802602B (zh) 醋酸棉酚海藻酸钙凝胶微球的制备方法
WO2006118137A1 (ja) ビグアナイド系薬物を含有する粒状製剤
JP2003119498A (ja) フィルム状の衣類洗濯用洗剤
US20230112989A1 (en) Particulate laundry composition
JP7262894B2 (ja) ゼリー剤造粒物、及び該ゼリー剤造粒物を含有する食品
JP2009096803A (ja) 口腔内貼付型徐溶性製剤
JP2019201607A (ja) 粘度低下方法及び粘度低下剤
JPWO2021086848A5 (https=)
CN104937091B (zh) 具有高螯合剂负载的可溶性含水凝胶